Gastric Inhibitory Polypeptide Receptor Market Report

Global and Region Gastric Inhibitory Polypeptide Receptor Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：172
  • REPORT CODE：GMM895361
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastric Inhibitory Polypeptide Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastric Inhibitory Polypeptide Receptormarket, defines the market attractiveness level of Gastric Inhibitory Polypeptide Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastric Inhibitory Polypeptide Receptor industry, describes the types of Gastric Inhibitory Polypeptide Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastric Inhibitory Polypeptide Receptor market and the development prospects and opportunities of Gastric Inhibitory Polypeptide Receptor industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastric Inhibitory Polypeptide Receptor market in Chapter 13.

    By Player:

    • Longevity Biotech, Inc

    • Sanofi

    • Carmot Therapeutics, Inc

    • AstraZeneca Plc

    • Novo Nordisk A/S

    • Diabetica Limited

    • Zealand Pharma A/S

    • Alchemia Limited

    By Type:

    • HM-15211

    • LBT-6030

    • LY-3298176

    • NNC-92041706

    • Others

    By End-User:

    • Metabolic Disorder

    • Type 2 Diabetes

    • Obesity

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastric Inhibitory Polypeptide Receptor Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastric Inhibitory Polypeptide Receptor Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastric Inhibitory Polypeptide Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastric Inhibitory Polypeptide Receptor Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastric Inhibitory Polypeptide Receptor Market Analysis and Outlook to 2022

    • 7.1 Global Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    • 7.2 United States Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    • 7.3 Europe Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    • 7.4 China Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    • 7.5 Japan Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    • 7.6 India Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    • 7.7 South Korea Gastric Inhibitory Polypeptide Receptor Consumption (2017-2022)

    8 Region and Country-wise Gastric Inhibitory Polypeptide Receptor Market Analysis and Outlook to 2028

    • 8.1 Global Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    • 8.2 United States Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    • 8.3 Europe Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    • 8.4 China Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    • 8.5 Japan Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    • 8.6 India Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastric Inhibitory Polypeptide Receptor Consumption Forecast (2022-2028)

    9 Global Gastric Inhibitory Polypeptide Receptor Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global HM-15211 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global LBT-6030 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global LY-3298176 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global NNC-92041706 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Metabolic Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Obesity Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastric Inhibitory Polypeptide Receptor Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global HM-15211 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global LBT-6030 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global LY-3298176 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global NNC-92041706 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Metabolic Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Obesity Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastric Inhibitory Polypeptide Receptor Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastric Inhibitory Polypeptide Receptor Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastric Inhibitory Polypeptide Receptor Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastric Inhibitory Polypeptide Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastric Inhibitory Polypeptide Receptor Market Competitive Analysis

    • 14.1 Longevity Biotech, Inc

      • 14.1.1 Longevity Biotech, Inc Company Details

      • 14.1.2 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.2 Sanofi

      • 14.2.1 Sanofi Company Details

      • 14.2.2 Sanofi Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.3 Carmot Therapeutics, Inc

      • 14.3.1 Carmot Therapeutics, Inc Company Details

      • 14.3.2 Carmot Therapeutics, Inc Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Carmot Therapeutics, Inc Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.4 AstraZeneca Plc

      • 14.4.1 AstraZeneca Plc Company Details

      • 14.4.2 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.5 Novo Nordisk A/S

      • 14.5.1 Novo Nordisk A/S Company Details

      • 14.5.2 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.6 Diabetica Limited

      • 14.6.1 Diabetica Limited Company Details

      • 14.6.2 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.7 Zealand Pharma A/S

      • 14.7.1 Zealand Pharma A/S Company Details

      • 14.7.2 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Product and Service

    • 14.8 Alchemia Limited

      • 14.8.1 Alchemia Limited Company Details

      • 14.8.2 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastric Inhibitory Polypeptide Receptor

    • Figure Gastric Inhibitory Polypeptide Receptor Picture

    • Table Global Gastric Inhibitory Polypeptide Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastric Inhibitory Polypeptide Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastric Inhibitory Polypeptide Receptor Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastric Inhibitory Polypeptide Receptor Consumption by Country (2017-2022)

    • Figure United States Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate (2017-2022)

    • Table Europe Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate (2017-2022)

    • Figure China Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate (2017-2022)

    • Figure India Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastric Inhibitory Polypeptide Receptor Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Inhibitory Polypeptide Receptor Consumption Forecast by Country (2022-2028)

    • Figure United States Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastric Inhibitory Polypeptide Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HM-15211 Consumption and Growth Rate (2017-2022)

    • Figure Global LBT-6030 Consumption and Growth Rate (2017-2022)

    • Figure Global LY-3298176 Consumption and Growth Rate (2017-2022)

    • Figure Global NNC-92041706 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global HM-15211 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LBT-6030 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LY-3298176 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NNC-92041706 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolic Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastric Inhibitory Polypeptide Receptor Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastric Inhibitory Polypeptide Receptor Export by Region (Top 5 Countries) (2017-2028)

    • Table Longevity Biotech, Inc (Foundation Year, Company Profile and etc.)

    • Table Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table Carmot Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Carmot Therapeutics, Inc Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Carmot Therapeutics, Inc Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table Diabetica Limited (Foundation Year, Company Profile and etc.)

    • Table Diabetica Limited Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Diabetica Limited Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table Zealand Pharma A/S (Foundation Year, Company Profile and etc.)

    • Table Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Product and Service

    • Table Alchemia Limited (Foundation Year, Company Profile and etc.)

    • Table Alchemia Limited Gastric Inhibitory Polypeptide Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alchemia Limited Gastric Inhibitory Polypeptide Receptor Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US